RedHill Biopharma (RDHL) Other Accumulated Expenses (2018 - 2025)
RedHill Biopharma's (RDHL) quarterly Other Accumulated Expenses came in at $500000.0 in Q4 2025, little changed year-over-year from $500000.0 in Q4 2024, and little changed quarter-over-quarter from $500000.0 in Q2 2025.
Powered by 
Analysis
RedHill Biopharma (RDHL) Other Accumulated Expenses (2018 - 2025) Analysis & Trends
RedHill Biopharma (RDHL) has reported Other Accumulated Expenses for 8 consecutive years, with $500000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Other Accumulated Expenses changed 0.0% year-over-year to $500000.0 in Q4 2025; TTM through Dec 2025 was $500000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $500000.0, changed 0.0% from the prior year.
- Other Accumulated Expenses was $500000.0 for Q4 2025 at RedHill Biopharma, roughly flat from $500000.0 in the prior quarter.
- Over five years, Other Accumulated Expenses peaked at $750000.0 in Q1 2021 and troughed at $500000.0 in Q4 2024.
- A 5-year average of $672000.0 and a median of $750000.0 in 2021 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses surged 50.0% in 2021 and dropped 28.0% in 2023, its largest moves.
- Over 5 years, Other Accumulated Expenses stood at $750000.0 in 2021, then changed by 0.0% to $750000.0 in 2022, then retreated by 28.0% to $540000.0 in 2023, then slipped by 7.41% to $500000.0 in 2024, then changed by 0.0% to $500000.0 in 2025.
- The last three Other Accumulated Expenses figures came in at $500000.0 (Q4 2025), $500000.0 (Q2 2025), and $500000.0 (Q4 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.72 Bn | 39.07 Bn | 2.15 Bn |
| 2 | Viatris | 19.14 Bn | 18.26 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.89 Bn | 9.71 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.46 Bn | 5.34 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.33 Bn | 494.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.48 Bn | 1.12 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 994.43 Mn | 704.31 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 399.34 Mn | 358.09 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.33 Mn | 178.33 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 500,000.00 |
| Jun 30, 2025 | 500,000.00 |
| Dec 31, 2024 | 500,000.00 |
| Jun 30, 2024 | 540,000.00 |
| Dec 31, 2023 | 540,000.00 |
| Jun 30, 2023 | 750,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Dec 31, 2022 | 750,000.00 |
| Sep 30, 2022 | 750,000.00 |
| Jun 30, 2022 | 750,000.00 |
| Mar 31, 2022 | 750,000.00 |
| Dec 31, 2021 | 750,000.00 |
| Sep 30, 2021 | 750,000.00 |
| Jun 30, 2021 | 750,000.00 |
| Mar 31, 2021 | 750,000.00 |
| Dec 31, 2020 | 750,000.00 |
| Sep 30, 2020 | 500,000.00 |
| Jun 30, 2020 | 500,000.00 |
| Mar 31, 2020 | 500,000.00 |
| Dec 31, 2019 | 500,000.00 |